Review



hek 293 cells  (AMS Biotechnology)


Bioz Verified Symbol AMS Biotechnology is a verified supplier
Bioz Manufacturer Symbol AMS Biotechnology manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    AMS Biotechnology hek 293 cells
    a Representative images of hMC4R GFP+ <t>HEK</t> <t>293</t> cells (green) 30 min after application of DyLight 550®-labeled (red) α-MSH affinity-purified IgG from eating disorder (anorexia nervosa, n = 9; bulimia nervosa, n = 7; binge eating disorder, n = 7), obese ( n = 10), and Ctrl ( n = 9) preincubated or not with α-MSH. Quantification of DyLight 550®-positive spots in hMC4R+ HEK 293 cells ( n = 50/group): b at the membrane; c intracellularly (cytosolic), and d ratios of cytosolic/membrane staining. Affinity kinetics properties of α-MSH/IgG IC for hMC4R + HEK 293 cells including e dissociation equilibrium constant (KD); f association rate (ka), and g dissociation rate (kd). Data are means ± s.e.m. Kruskal–Wallis test with Dunns’ post-tests ( b – d , f , g ) or analysis of variance with Tukey’s post-test ( e ), *** p < 0.001, ** p < 0.01, * p < 0.05
    Hek 293 Cells, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ep-cl-0001/pmc06372612-41-1-4?v=AMS+Biotechnology
    Average 96 stars, based on 1 article reviews
    hek 293 cells - by Bioz Stars, 2026-07
    96/100 stars

    Images

    1) Product Images from "Immunoglobulin G modulation of the melanocortin 4 receptor signaling in obesity and eating disorders"

    Article Title: Immunoglobulin G modulation of the melanocortin 4 receptor signaling in obesity and eating disorders

    Journal: Translational Psychiatry

    doi: 10.1038/s41398-019-0422-9

    a Representative images of hMC4R GFP+ HEK 293 cells (green) 30 min after application of DyLight 550®-labeled (red) α-MSH affinity-purified IgG from eating disorder (anorexia nervosa, n = 9; bulimia nervosa, n = 7; binge eating disorder, n = 7), obese ( n = 10), and Ctrl ( n = 9) preincubated or not with α-MSH. Quantification of DyLight 550®-positive spots in hMC4R+ HEK 293 cells ( n = 50/group): b at the membrane; c intracellularly (cytosolic), and d ratios of cytosolic/membrane staining. Affinity kinetics properties of α-MSH/IgG IC for hMC4R + HEK 293 cells including e dissociation equilibrium constant (KD); f association rate (ka), and g dissociation rate (kd). Data are means ± s.e.m. Kruskal–Wallis test with Dunns’ post-tests ( b – d , f , g ) or analysis of variance with Tukey’s post-test ( e ), *** p < 0.001, ** p < 0.01, * p < 0.05
    Figure Legend Snippet: a Representative images of hMC4R GFP+ HEK 293 cells (green) 30 min after application of DyLight 550®-labeled (red) α-MSH affinity-purified IgG from eating disorder (anorexia nervosa, n = 9; bulimia nervosa, n = 7; binge eating disorder, n = 7), obese ( n = 10), and Ctrl ( n = 9) preincubated or not with α-MSH. Quantification of DyLight 550®-positive spots in hMC4R+ HEK 293 cells ( n = 50/group): b at the membrane; c intracellularly (cytosolic), and d ratios of cytosolic/membrane staining. Affinity kinetics properties of α-MSH/IgG IC for hMC4R + HEK 293 cells including e dissociation equilibrium constant (KD); f association rate (ka), and g dissociation rate (kd). Data are means ± s.e.m. Kruskal–Wallis test with Dunns’ post-tests ( b – d , f , g ) or analysis of variance with Tukey’s post-test ( e ), *** p < 0.001, ** p < 0.01, * p < 0.05

    Techniques Used: Labeling, Affinity Purification, Staining

    a cAMP dose–response curves to α-MSH alone or α-MSH/IgG IC formed by IgG pooled in patents and control groups and adjusted to α-MSH-reactive IgG plasma levels of controls. cAMP dose–response curves to α-MSH preincubated or not with individual total IgG and corresponding EC50 ( b ) and maximal cAMP production ( c ). d Control experiments including cAMP dose–response curves to α-MSH by MC4R-expressing and non-expressing control HEK 293 cells and to α-MSH 1–4 peptide by MC4R-expressing cells ( n = 4). e cAMP dose-response curves to α-MSH and IgG from patients and controls without their overnight pre-incubation. f , cAMP dose–response curves to α-MSH alone or α-MSH/IgG IC co-administered (solid line) with agouti-related protein (AgRP; 100 nM) or added after AgRP preincubation (dotted line— n = 2/group) as well as in g cAMP maximal response. h , i cAMP dose–response curves of α-MSH preincubated with h purified total IgG from patients and controls depleted for α-MSH-reactive IgG ( n = 3/group) and i affinity-purified α-MSH-reactive IgG ( n = 6/group); j EC 50 and k maximal cAMP production at the plateau. Data are means ± s.e.m. Analysis of variance with Tukey’s post-test ( b , c , g , j ) or Kruskal–Wallis test with Dunns’ post-tests ( m ), *** p < 0.001, ** p < 0.01, * p < 0.05; Mann–Whitney test, $ p < 0.05. a α-MSH ( n = 9), Ctrl, anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED; n = 6), obese (OB; n = 4); d HEK 293-hMC4R+ ( n = 5), HEK 293-CTRL ( n = 6); e α-MSH ( n = 3), Ctrl, BN, and BED ( n = 2), AN and OB ( n = 3)
    Figure Legend Snippet: a cAMP dose–response curves to α-MSH alone or α-MSH/IgG IC formed by IgG pooled in patents and control groups and adjusted to α-MSH-reactive IgG plasma levels of controls. cAMP dose–response curves to α-MSH preincubated or not with individual total IgG and corresponding EC50 ( b ) and maximal cAMP production ( c ). d Control experiments including cAMP dose–response curves to α-MSH by MC4R-expressing and non-expressing control HEK 293 cells and to α-MSH 1–4 peptide by MC4R-expressing cells ( n = 4). e cAMP dose-response curves to α-MSH and IgG from patients and controls without their overnight pre-incubation. f , cAMP dose–response curves to α-MSH alone or α-MSH/IgG IC co-administered (solid line) with agouti-related protein (AgRP; 100 nM) or added after AgRP preincubation (dotted line— n = 2/group) as well as in g cAMP maximal response. h , i cAMP dose–response curves of α-MSH preincubated with h purified total IgG from patients and controls depleted for α-MSH-reactive IgG ( n = 3/group) and i affinity-purified α-MSH-reactive IgG ( n = 6/group); j EC 50 and k maximal cAMP production at the plateau. Data are means ± s.e.m. Analysis of variance with Tukey’s post-test ( b , c , g , j ) or Kruskal–Wallis test with Dunns’ post-tests ( m ), *** p < 0.001, ** p < 0.01, * p < 0.05; Mann–Whitney test, $ p < 0.05. a α-MSH ( n = 9), Ctrl, anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED; n = 6), obese (OB; n = 4); d HEK 293-hMC4R+ ( n = 5), HEK 293-CTRL ( n = 6); e α-MSH ( n = 3), Ctrl, BN, and BED ( n = 2), AN and OB ( n = 3)

    Techniques Used: Expressing, Incubation, Purification, Affinity Purification, MANN-WHITNEY



    Similar Products

    96
    AMS Biotechnology hek 293 cells
    a Representative images of hMC4R GFP+ <t>HEK</t> <t>293</t> cells (green) 30 min after application of DyLight 550®-labeled (red) α-MSH affinity-purified IgG from eating disorder (anorexia nervosa, n = 9; bulimia nervosa, n = 7; binge eating disorder, n = 7), obese ( n = 10), and Ctrl ( n = 9) preincubated or not with α-MSH. Quantification of DyLight 550®-positive spots in hMC4R+ HEK 293 cells ( n = 50/group): b at the membrane; c intracellularly (cytosolic), and d ratios of cytosolic/membrane staining. Affinity kinetics properties of α-MSH/IgG IC for hMC4R + HEK 293 cells including e dissociation equilibrium constant (KD); f association rate (ka), and g dissociation rate (kd). Data are means ± s.e.m. Kruskal–Wallis test with Dunns’ post-tests ( b – d , f , g ) or analysis of variance with Tukey’s post-test ( e ), *** p < 0.001, ** p < 0.01, * p < 0.05
    Hek 293 Cells, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ep-cl-0001/pmc06372612-41-1-4?v=AMS+Biotechnology
    Average 96 stars, based on 1 article reviews
    hek 293 cells - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    95
    Elabscience Biotechnology hek 293 cells
    a Representative images of hMC4R GFP+ <t>HEK</t> <t>293</t> cells (green) 30 min after application of DyLight 550®-labeled (red) α-MSH affinity-purified IgG from eating disorder (anorexia nervosa, n = 9; bulimia nervosa, n = 7; binge eating disorder, n = 7), obese ( n = 10), and Ctrl ( n = 9) preincubated or not with α-MSH. Quantification of DyLight 550®-positive spots in hMC4R+ HEK 293 cells ( n = 50/group): b at the membrane; c intracellularly (cytosolic), and d ratios of cytosolic/membrane staining. Affinity kinetics properties of α-MSH/IgG IC for hMC4R + HEK 293 cells including e dissociation equilibrium constant (KD); f association rate (ka), and g dissociation rate (kd). Data are means ± s.e.m. Kruskal–Wallis test with Dunns’ post-tests ( b – d , f , g ) or analysis of variance with Tukey’s post-test ( e ), *** p < 0.001, ** p < 0.01, * p < 0.05
    Hek 293 Cells, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ep-cl-0001/pm38133486-50-30-46?v=Elabscience+Biotechnology
    Average 95 stars, based on 1 article reviews
    hek 293 cells - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    90
    IoLiTec Ionic Liquids Technologies GmbH alcl 3 -1-ethyl-3-methylimidazolium chloride ([emim]cl) with 3:2 concentration ratio ep-0001
    a Representative images of hMC4R GFP+ <t>HEK</t> <t>293</t> cells (green) 30 min after application of DyLight 550®-labeled (red) α-MSH affinity-purified IgG from eating disorder (anorexia nervosa, n = 9; bulimia nervosa, n = 7; binge eating disorder, n = 7), obese ( n = 10), and Ctrl ( n = 9) preincubated or not with α-MSH. Quantification of DyLight 550®-positive spots in hMC4R+ HEK 293 cells ( n = 50/group): b at the membrane; c intracellularly (cytosolic), and d ratios of cytosolic/membrane staining. Affinity kinetics properties of α-MSH/IgG IC for hMC4R + HEK 293 cells including e dissociation equilibrium constant (KD); f association rate (ka), and g dissociation rate (kd). Data are means ± s.e.m. Kruskal–Wallis test with Dunns’ post-tests ( b – d , f , g ) or analysis of variance with Tukey’s post-test ( e ), *** p < 0.001, ** p < 0.01, * p < 0.05
    Alcl 3 1 Ethyl 3 Methylimidazolium Chloride ([Emim]Cl) With 3:2 Concentration Ratio Ep 0001, supplied by IoLiTec Ionic Liquids Technologies GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ep-cl-0001/pmc09413586-109-10-13?v=IoLiTec+Ionic+Liquids+Technologies+GmbH
    Average 90 stars, based on 1 article reviews
    alcl 3 -1-ethyl-3-methylimidazolium chloride ([emim]cl) with 3:2 concentration ratio ep-0001 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    96
    AMS Biotechnology embryonic kidney hek 293 cells
    Characterisation of Lin28A over-expression in <t>HEK</t> <t>293</t> cells. Real-time PCR revealed that Lin28 mRNA expression levels were increased in Lin28A over-expressing cells, n = 3 ( a ). Conversely, Let 7 a, c and g miRNA expression levels were decreased in Lin28 over-expressing cells, n = 3 ( b ). Western blot analysis ( c ) confirmed that Lin28 protein levels were also increased in over-expressing HEK cells ( d ), n = 4. GAPDH and U6 were used as housekeeping genes for mRNA and miRNA expression, respectively. Student’s unpaired t-tests were used to compare between experimental groups. Data are represented as mean ± SEM. HEK human embryonic kidney, miRNA microRNA
    Embryonic Kidney Hek 293 Cells, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ep-cl-0001/pmc04882770-29-3-11?v=AMS+Biotechnology
    Average 96 stars, based on 1 article reviews
    embryonic kidney hek 293 cells - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    Image Search Results


    a Representative images of hMC4R GFP+ HEK 293 cells (green) 30 min after application of DyLight 550®-labeled (red) α-MSH affinity-purified IgG from eating disorder (anorexia nervosa, n = 9; bulimia nervosa, n = 7; binge eating disorder, n = 7), obese ( n = 10), and Ctrl ( n = 9) preincubated or not with α-MSH. Quantification of DyLight 550®-positive spots in hMC4R+ HEK 293 cells ( n = 50/group): b at the membrane; c intracellularly (cytosolic), and d ratios of cytosolic/membrane staining. Affinity kinetics properties of α-MSH/IgG IC for hMC4R + HEK 293 cells including e dissociation equilibrium constant (KD); f association rate (ka), and g dissociation rate (kd). Data are means ± s.e.m. Kruskal–Wallis test with Dunns’ post-tests ( b – d , f , g ) or analysis of variance with Tukey’s post-test ( e ), *** p < 0.001, ** p < 0.01, * p < 0.05

    Journal: Translational Psychiatry

    Article Title: Immunoglobulin G modulation of the melanocortin 4 receptor signaling in obesity and eating disorders

    doi: 10.1038/s41398-019-0422-9

    Figure Lengend Snippet: a Representative images of hMC4R GFP+ HEK 293 cells (green) 30 min after application of DyLight 550®-labeled (red) α-MSH affinity-purified IgG from eating disorder (anorexia nervosa, n = 9; bulimia nervosa, n = 7; binge eating disorder, n = 7), obese ( n = 10), and Ctrl ( n = 9) preincubated or not with α-MSH. Quantification of DyLight 550®-positive spots in hMC4R+ HEK 293 cells ( n = 50/group): b at the membrane; c intracellularly (cytosolic), and d ratios of cytosolic/membrane staining. Affinity kinetics properties of α-MSH/IgG IC for hMC4R + HEK 293 cells including e dissociation equilibrium constant (KD); f association rate (ka), and g dissociation rate (kd). Data are means ± s.e.m. Kruskal–Wallis test with Dunns’ post-tests ( b – d , f , g ) or analysis of variance with Tukey’s post-test ( e ), *** p < 0.001, ** p < 0.01, * p < 0.05

    Article Snippet: MC4R-expressing HEK 293 cells (AMS Biotechnology, Abingdon, UK) were cultured in glass bottom Petri dishes (MatTek, ≈250,000 cells/dish).

    Techniques: Labeling, Affinity Purification, Staining

    a cAMP dose–response curves to α-MSH alone or α-MSH/IgG IC formed by IgG pooled in patents and control groups and adjusted to α-MSH-reactive IgG plasma levels of controls. cAMP dose–response curves to α-MSH preincubated or not with individual total IgG and corresponding EC50 ( b ) and maximal cAMP production ( c ). d Control experiments including cAMP dose–response curves to α-MSH by MC4R-expressing and non-expressing control HEK 293 cells and to α-MSH 1–4 peptide by MC4R-expressing cells ( n = 4). e cAMP dose-response curves to α-MSH and IgG from patients and controls without their overnight pre-incubation. f , cAMP dose–response curves to α-MSH alone or α-MSH/IgG IC co-administered (solid line) with agouti-related protein (AgRP; 100 nM) or added after AgRP preincubation (dotted line— n = 2/group) as well as in g cAMP maximal response. h , i cAMP dose–response curves of α-MSH preincubated with h purified total IgG from patients and controls depleted for α-MSH-reactive IgG ( n = 3/group) and i affinity-purified α-MSH-reactive IgG ( n = 6/group); j EC 50 and k maximal cAMP production at the plateau. Data are means ± s.e.m. Analysis of variance with Tukey’s post-test ( b , c , g , j ) or Kruskal–Wallis test with Dunns’ post-tests ( m ), *** p < 0.001, ** p < 0.01, * p < 0.05; Mann–Whitney test, $ p < 0.05. a α-MSH ( n = 9), Ctrl, anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED; n = 6), obese (OB; n = 4); d HEK 293-hMC4R+ ( n = 5), HEK 293-CTRL ( n = 6); e α-MSH ( n = 3), Ctrl, BN, and BED ( n = 2), AN and OB ( n = 3)

    Journal: Translational Psychiatry

    Article Title: Immunoglobulin G modulation of the melanocortin 4 receptor signaling in obesity and eating disorders

    doi: 10.1038/s41398-019-0422-9

    Figure Lengend Snippet: a cAMP dose–response curves to α-MSH alone or α-MSH/IgG IC formed by IgG pooled in patents and control groups and adjusted to α-MSH-reactive IgG plasma levels of controls. cAMP dose–response curves to α-MSH preincubated or not with individual total IgG and corresponding EC50 ( b ) and maximal cAMP production ( c ). d Control experiments including cAMP dose–response curves to α-MSH by MC4R-expressing and non-expressing control HEK 293 cells and to α-MSH 1–4 peptide by MC4R-expressing cells ( n = 4). e cAMP dose-response curves to α-MSH and IgG from patients and controls without their overnight pre-incubation. f , cAMP dose–response curves to α-MSH alone or α-MSH/IgG IC co-administered (solid line) with agouti-related protein (AgRP; 100 nM) or added after AgRP preincubation (dotted line— n = 2/group) as well as in g cAMP maximal response. h , i cAMP dose–response curves of α-MSH preincubated with h purified total IgG from patients and controls depleted for α-MSH-reactive IgG ( n = 3/group) and i affinity-purified α-MSH-reactive IgG ( n = 6/group); j EC 50 and k maximal cAMP production at the plateau. Data are means ± s.e.m. Analysis of variance with Tukey’s post-test ( b , c , g , j ) or Kruskal–Wallis test with Dunns’ post-tests ( m ), *** p < 0.001, ** p < 0.01, * p < 0.05; Mann–Whitney test, $ p < 0.05. a α-MSH ( n = 9), Ctrl, anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED; n = 6), obese (OB; n = 4); d HEK 293-hMC4R+ ( n = 5), HEK 293-CTRL ( n = 6); e α-MSH ( n = 3), Ctrl, BN, and BED ( n = 2), AN and OB ( n = 3)

    Article Snippet: MC4R-expressing HEK 293 cells (AMS Biotechnology, Abingdon, UK) were cultured in glass bottom Petri dishes (MatTek, ≈250,000 cells/dish).

    Techniques: Expressing, Incubation, Purification, Affinity Purification, MANN-WHITNEY

    Characterisation of Lin28A over-expression in HEK 293 cells. Real-time PCR revealed that Lin28 mRNA expression levels were increased in Lin28A over-expressing cells, n = 3 ( a ). Conversely, Let 7 a, c and g miRNA expression levels were decreased in Lin28 over-expressing cells, n = 3 ( b ). Western blot analysis ( c ) confirmed that Lin28 protein levels were also increased in over-expressing HEK cells ( d ), n = 4. GAPDH and U6 were used as housekeeping genes for mRNA and miRNA expression, respectively. Student’s unpaired t-tests were used to compare between experimental groups. Data are represented as mean ± SEM. HEK human embryonic kidney, miRNA microRNA

    Journal: Stem Cell Research & Therapy

    Article Title: Lin28A induces energetic switching to glycolytic metabolism in human embryonic kidney cells

    doi: 10.1186/s13287-016-0323-2

    Figure Lengend Snippet: Characterisation of Lin28A over-expression in HEK 293 cells. Real-time PCR revealed that Lin28 mRNA expression levels were increased in Lin28A over-expressing cells, n = 3 ( a ). Conversely, Let 7 a, c and g miRNA expression levels were decreased in Lin28 over-expressing cells, n = 3 ( b ). Western blot analysis ( c ) confirmed that Lin28 protein levels were also increased in over-expressing HEK cells ( d ), n = 4. GAPDH and U6 were used as housekeeping genes for mRNA and miRNA expression, respectively. Student’s unpaired t-tests were used to compare between experimental groups. Data are represented as mean ± SEM. HEK human embryonic kidney, miRNA microRNA

    Article Snippet: Lin28A over-expressing human embryonic kidney (HEK) 293 cells were obtained from Amsbio, UK.

    Techniques: Over Expression, Real-time Polymerase Chain Reaction, Expressing, Western Blot

    Lin28A increases cellular proliferation and glucose transport in HEK 293 cells. Proliferation studies revealed that cell density was significantly increased at 72 and 96 hour time points in Lin28A over-expressing cells compared to non-transfected (blank) HEK cells, n = 3 ( a ). Radio-labelled glucose transport assay revealed that 2-deoxyglucose transport was also significantly increased in the Lin28A over-expressing cells (P < 0.01, n = 6) ( b ). Student’s unpaired t-tests were used to compare between experimental groups. Data are represented as mean ± SEM. HEK human embryonic kidney

    Journal: Stem Cell Research & Therapy

    Article Title: Lin28A induces energetic switching to glycolytic metabolism in human embryonic kidney cells

    doi: 10.1186/s13287-016-0323-2

    Figure Lengend Snippet: Lin28A increases cellular proliferation and glucose transport in HEK 293 cells. Proliferation studies revealed that cell density was significantly increased at 72 and 96 hour time points in Lin28A over-expressing cells compared to non-transfected (blank) HEK cells, n = 3 ( a ). Radio-labelled glucose transport assay revealed that 2-deoxyglucose transport was also significantly increased in the Lin28A over-expressing cells (P < 0.01, n = 6) ( b ). Student’s unpaired t-tests were used to compare between experimental groups. Data are represented as mean ± SEM. HEK human embryonic kidney

    Article Snippet: Lin28A over-expressing human embryonic kidney (HEK) 293 cells were obtained from Amsbio, UK.

    Techniques: Expressing, Transfection, Transport Assay